article Open AccessTop 1% cited
Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy
BMC Cancer · 2013 · Vol. 13(1) · pp. 350–350
Suee Lee✉(Dong-A University)Sung Yong Oh(Dong-A University)Sung Hyun Kim(Dong-A University)Ji Hyun Lee(Dong-A University)Min Chan Kim(Dong-A University)Ki Han Kim(Dong-A University)Hyojin Kim(Dong-A University)
Abstract
This study demonstrates that NLR, PLR, and changes in NLR or PLR are independent prognostic factor for OS in patients with advanced gastric cancer treated with chemotherapy. These specific factors may also help in identifying the patients, who are more sensitive to FOLFOX regimen.
Inflammatory Biomarkers in Disease PrognosisCholangiocarcinoma and Gallbladder Cancer StudiesCancer, Lipids, and MetabolismMedicineFOLFOXNeutrophil to lymphocyte ratioSurgical oncologyLymphocyteInternal medicineChemotherapyOncologyPlateletCancer
MeSH terms
AdenocarcinomaAdultAgedAntineoplastic Combined Chemotherapy ProtocolsBlood PlateletsLeucovorinFemaleFluorouracilHumansLeukocyte CountLymphocytesMaleMiddle AgedNeutrophilsOrganoplatinum Compounds
Funding
- Dong-A University
Citations
284
FWCI
12.86
field-weighted impact
References
26
Percentile
99%
vs. same field & year
Citations per year
References
Inflammation and cancer
Nature · 2002 · 14,998 citations
Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma
The American Journal of Surgery · 2008 · 457 citations
Global Cancer Statistics, 2002
CA A Cancer Journal for Clinicians · 2005 · 18,373 citations
Global cancer statistics
CA A Cancer Journal for Clinicians · 2011 · 55,006 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.